Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-04

Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab in combination with temozolomide and radiotherapy for pediatric and adolescent high-grade glioma has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • Temozolomide (Temozolomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: High Grade Glioma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-04